Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.40p
   
  • Change Today:
    -0.050p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 336,570
  • Market Cap: £25.00m
  • Beta: 0.00

Regulatory News

Result of AGM 22-May-2025 17:06 RNS
Audited results for the year ended 31 Dec 2024 24-Apr-2025 07:06 RNS
Licence Agreement in Japan for ACCRUFeR® 22-Apr-2025 07:01 RNS
Q1 2025 Trading Update 17-Apr-2025 11:23 RNS
ACCRUFeR® launched in Canada 11-Mar-2025 07:00 RNS
PDMR Transaction Notification 13-Feb-2025 16:15 RNS
Grant of Share Options 13-Feb-2025 07:00 RNS
Unaudited full year trading update 05-Feb-2025 07:00 RNS
Anders Lundstrom appointed CEO 27-Jan-2025 07:00 RNS
Result of General Meeting & Total Voting Rights 24-Dec-2024 11:25 RNS
Results of RetailBook Offer 23-Dec-2024 07:00 RNS
RetailBook Offer 06-Dec-2024 11:31 RNS
Subscription by AOP Health to raise US$10 million 06-Dec-2024 11:30 RNS
Business Update 21-Nov-2024 07:00 RNS
Q3 Trading Update 29-Oct-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.40p
Change Today -0.050p
% Change -2.04 %
52 Week High 5.34
52 Week Low 1.60
Volume 336,570
Shares Issued 1,041.69m
Market Cap £25.00m
Beta 0.00

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.44% below the market average12.44% below the market average12.44% below the market average12.44% below the market average12.44% below the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Price Trend
33.25% below the market average33.25% below the market average33.25% below the market average33.25% below the market average33.25% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Income Not Available
Growth
62.54% above the market average62.54% above the market average62.54% above the market average62.54% above the market average62.54% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
16:19 10,000 @ 2.42p
16:12 80,000 @ 2.33p
15:57 42,016 @ 2.38p
15:41 5,676 @ 2.33p
14:41 6,600 @ 2.44p

STX Key Personnel

CEO Anders Lundstrom

Top of Page